T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles

Glioblastoma is a highly aggressive, and also the most common, brain tumour type in adults. Here, the authors generate a nanoparticle encapsulating the TLR7/8 agonist, R848, which induces tumour regression in mice by reprogramming myeloid cells independently of T and NK cells.

Bibliographic Details
Main Authors: Verena Turco, Kira Pfleiderer, Jessica Hunger, Natalie K. Horvat, Kianush Karimian-Jazi, Katharina Schregel, Manuel Fischer, Gianluca Brugnara, Kristine Jähne, Volker Sturm, Yannik Streibel, Duy Nguyen, Sandro Altamura, Dennis A. Agardy, Shreya S. Soni, Abdulrahman Alsasa, Theresa Bunse, Matthias Schlesner, Martina U. Muckenthaler, Ralph Weissleder, Wolfgang Wick, Sabine Heiland, Philipp Vollmuth, Martin Bendszus, Christopher B. Rodell, Michael O. Breckwoldt, Michael Platten
Format: Article
Language:English
Published: Nature Portfolio 2023-02-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-36321-6
_version_ 1811165815618142208
author Verena Turco
Kira Pfleiderer
Jessica Hunger
Natalie K. Horvat
Kianush Karimian-Jazi
Katharina Schregel
Manuel Fischer
Gianluca Brugnara
Kristine Jähne
Volker Sturm
Yannik Streibel
Duy Nguyen
Sandro Altamura
Dennis A. Agardy
Shreya S. Soni
Abdulrahman Alsasa
Theresa Bunse
Matthias Schlesner
Martina U. Muckenthaler
Ralph Weissleder
Wolfgang Wick
Sabine Heiland
Philipp Vollmuth
Martin Bendszus
Christopher B. Rodell
Michael O. Breckwoldt
Michael Platten
author_facet Verena Turco
Kira Pfleiderer
Jessica Hunger
Natalie K. Horvat
Kianush Karimian-Jazi
Katharina Schregel
Manuel Fischer
Gianluca Brugnara
Kristine Jähne
Volker Sturm
Yannik Streibel
Duy Nguyen
Sandro Altamura
Dennis A. Agardy
Shreya S. Soni
Abdulrahman Alsasa
Theresa Bunse
Matthias Schlesner
Martina U. Muckenthaler
Ralph Weissleder
Wolfgang Wick
Sabine Heiland
Philipp Vollmuth
Martin Bendszus
Christopher B. Rodell
Michael O. Breckwoldt
Michael Platten
author_sort Verena Turco
collection DOAJ
description Glioblastoma is a highly aggressive, and also the most common, brain tumour type in adults. Here, the authors generate a nanoparticle encapsulating the TLR7/8 agonist, R848, which induces tumour regression in mice by reprogramming myeloid cells independently of T and NK cells.
first_indexed 2024-04-10T15:42:57Z
format Article
id doaj.art-0f85af58c6e64df3af7a9ef3d9fc543c
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-10T15:42:57Z
publishDate 2023-02-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-0f85af58c6e64df3af7a9ef3d9fc543c2023-02-12T12:16:01ZengNature PortfolioNature Communications2041-17232023-02-0114111510.1038/s41467-023-36321-6T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticlesVerena Turco0Kira Pfleiderer1Jessica Hunger2Natalie K. Horvat3Kianush Karimian-Jazi4Katharina Schregel5Manuel Fischer6Gianluca Brugnara7Kristine Jähne8Volker Sturm9Yannik Streibel10Duy Nguyen11Sandro Altamura12Dennis A. Agardy13Shreya S. Soni14Abdulrahman Alsasa15Theresa Bunse16Matthias Schlesner17Martina U. Muckenthaler18Ralph Weissleder19Wolfgang Wick20Sabine Heiland21Philipp Vollmuth22Martin Bendszus23Christopher B. Rodell24Michael O. Breckwoldt25Michael Platten26Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Consortium (DKTK) within the German Cancer Research Center (DKFZ)Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Consortium (DKTK) within the German Cancer Research Center (DKFZ)Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Consortium (DKTK) within the German Cancer Research Center (DKFZ)Faculty of Biosciences, Heidelberg UniversityNeuroradiology Department, University Hospital HeidelbergNeuroradiology Department, University Hospital HeidelbergNeuroradiology Department, University Hospital HeidelbergNeuroradiology Department, University Hospital HeidelbergClinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Consortium (DKTK) within the German Cancer Research Center (DKFZ)Neuroradiology Department, University Hospital HeidelbergNeuroradiology Department, University Hospital HeidelbergJunior Research Group Bioinformatics and Omics Data Analytics, DKFZDepartment of Pediatric Oncology, Hematology and Immunology, University HospitalClinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Consortium (DKTK) within the German Cancer Research Center (DKFZ)School of Biomedical Engineering, Science and Health Systems, Drexel UniversitySchool of Biomedical Engineering, Science and Health Systems, Drexel UniversityClinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Consortium (DKTK) within the German Cancer Research Center (DKFZ)Junior Research Group Bioinformatics and Omics Data Analytics, DKFZDepartment of Pediatric Oncology, Hematology and Immunology, University HospitalCenter for Systems Biology, Massachusetts General HospitalClinical Cooperation Unit Neurooncology, DKTK within DKFZNeuroradiology Department, University Hospital HeidelbergNeuroradiology Department, University Hospital HeidelbergNeuroradiology Department, University Hospital HeidelbergSchool of Biomedical Engineering, Science and Health Systems, Drexel UniversityClinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Consortium (DKTK) within the German Cancer Research Center (DKFZ)Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Consortium (DKTK) within the German Cancer Research Center (DKFZ)Glioblastoma is a highly aggressive, and also the most common, brain tumour type in adults. Here, the authors generate a nanoparticle encapsulating the TLR7/8 agonist, R848, which induces tumour regression in mice by reprogramming myeloid cells independently of T and NK cells.https://doi.org/10.1038/s41467-023-36321-6
spellingShingle Verena Turco
Kira Pfleiderer
Jessica Hunger
Natalie K. Horvat
Kianush Karimian-Jazi
Katharina Schregel
Manuel Fischer
Gianluca Brugnara
Kristine Jähne
Volker Sturm
Yannik Streibel
Duy Nguyen
Sandro Altamura
Dennis A. Agardy
Shreya S. Soni
Abdulrahman Alsasa
Theresa Bunse
Matthias Schlesner
Martina U. Muckenthaler
Ralph Weissleder
Wolfgang Wick
Sabine Heiland
Philipp Vollmuth
Martin Bendszus
Christopher B. Rodell
Michael O. Breckwoldt
Michael Platten
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Nature Communications
title T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
title_full T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
title_fullStr T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
title_full_unstemmed T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
title_short T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
title_sort t cell independent eradication of experimental glioma by intravenous tlr7 8 agonist loaded nanoparticles
url https://doi.org/10.1038/s41467-023-36321-6
work_keys_str_mv AT verenaturco tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT kirapfleiderer tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT jessicahunger tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT nataliekhorvat tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT kianushkarimianjazi tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT katharinaschregel tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT manuelfischer tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT gianlucabrugnara tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT kristinejahne tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT volkersturm tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT yannikstreibel tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT duynguyen tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT sandroaltamura tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT dennisaagardy tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT shreyassoni tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT abdulrahmanalsasa tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT theresabunse tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT matthiasschlesner tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT martinaumuckenthaler tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT ralphweissleder tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT wolfgangwick tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT sabineheiland tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT philippvollmuth tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT martinbendszus tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT christopherbrodell tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT michaelobreckwoldt tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles
AT michaelplatten tcellindependenteradicationofexperimentalgliomabyintravenoustlr78agonistloadednanoparticles